EU-China Seminar on Quality Related Regulations on Pharmaceutical Products Held in Beijing
From July 11 to 12, EU-China seminar on quality related regulations on pharmaceutical products was held in Beijing. The seminar was sponsored by MOFCOM, SFDA and DG SANCO, supported by CCCMHPIE and EU-China Trade Project (Ⅱ). About 260 representatives from both European and China government and enterprises attended the meeting. The representatives carried out extensive exchanges on GPM in EU and China, Dir.2011/62/EU and other hot issues. The seminar was successful and achieved the desired result.
As the largest API export country, China makes a big contribution to world pharmaceutical industry. EU is an important trade partner of China. The value of China’s API export to EU in 2011 was 5.48 billion USD, with an increase of 22.38%.
Both sides government paid a high attention to the seminar and held a high-level dialogue. Mr. Huang Rengang, the deputy director general of department of WTO affairs, MOFCOM, Mr. Li Maozhong, the deputy director general of department of Drug registration, SFDA, Dr. Guido Rasi, executive director of European Medicine Agency delivered speeches, discussing on the issues in GMP, current situation and future perspective in pharmaceutical trade.
Mr Guo Qingwu, head of Drug Manufacturer Supervision Division, SFDA, Mr. Qian Zhongzhi, Chief scientist of Chinese Pharmacopoeia, attended the seminar and introduced the main issues in update on China GMP and the Chinese pharmacopoeia. Mr. Zhangwei, Director General, Drug Registration Department of SFDA, made a conclusion and spoke highly of the seminar. Mr. Jeome Lepeintre, DG SANCO’s future representative in China, Mr. Thomas Heynish, head of European Commission - Enterprise and Industry Division, MS Emer Cooke, head of sector, EMA, Mr David Cockburn, head of division of GMP, EMA, Mr. Maria Riguerola, SANCO/D5, European Commission, Mr. Heddal, head of department of MHRA(UK), Dr. MARTA, head of API inspectorate, Agenzia Italiana del Farmaco, Ms. Keitel, Director of European Directorate for the Quality of Medicines & HealthCare participated the seminar and made speeches.
The principal of EGA, EFPIA and EFCG, high level officials of Novo Nordisk, GlaxoSmithKline also participated the seminar and discussion. Liu Zhanglin and Meng Dongping, vice presidents of CCCMHPIE had deep exchanges with guests. Representatives of China office of FDA, RDPAC attended the seminar too.
The seminar set up a platform which made a big contribution to the communication between China and EU government, industry and enterprise. It had a special significance in deepening understanding between both sides and promoting bilateral trade.